Monday, November 28, 2022

Hospitals Complying to CMS Price Transparency Requirements

Sponsored by Cleverley + Associates


 

On January 1, 2021, The Centers for Medicare and Medicaid Services (CMS) implemented the Hospital Price Transparency Rule.  This rule states that hospitals in the United States must disclose the prices of items and services for any separately negotiated payer in two ways, which are deemed clear and accessible to users:

  • Through a comprehensive machine readable format 
  • A consumer-friendly ‘shoppable’ format on their website

Continue below to read a review of a survey completed by Cleverley + Associates to see how hospitals are complying with CMS’s price transparency requirements.

 

CMS Price Transparency Requirements

As we continue our research into Price Transparency (you can see our full Spring Summit on the topic here), one of the things we wanted to know is are hospitals complying and, if so, how?

We conducted a survey of hospitals and took a close look at their approaches to the new Price Transparency requirements. Here’s what we found.

Our Methodology


A breakdown of our research group, 137 health systems with 10+ hospitals.

Our research reviewed 137 health systems with 10+ hospitals within the health system itself, which represented 3,358 hospitals in total. We used the health systems webpage and their search engines to look for the Price Transparency files. We searched basic keywords such as machine readable, pricing transparency, pricing, standard charges, and charges.

Of those 137 health systems we found that 100 of them offered a dedicated system level website for pricing transparency. Our observations for the two reporting requirements – a machine-readable file and a consumer-friendly disclosure are as follows:

Machine Readable Results

Our major finding was that 40 of these systems met CMS’ Price Transparency requirements, meaning their files included all of the required charge criteria.  Of the 137 health systems, we did find significant variation in what standard charge elements were being disclosed:

  • 85% represented the gross charges within their machine-readable file
  • 48% provided the discount cash price policy
  • 40% provided the deidentified MIN/MAX values of the payer-specific charges
  • 36% disclosed payer-specific charges
  • 15% did not post any information at all

We only found 4% of those files represented some level of employed professional charges. This may be because there is still some confusion as to the definition of employed within the rule.

File Types (this is going to be a sub heading in the final)

We also found that there’s wide variation as far as what file types hospitals are using to display their Price Transparency information. The types of files used in posting the transparency files were:

  • 38% Excel,
  • 28% CSV,
  • 12% JSON
  • 11% Web/Tool
  • 8% TXT
  • 3% XML


Congress recently sent a letter to the Department of Health and Human services calling out format specifically. They wrote, “some hospitals… are providing the data in a non-usable format or failing to provide codes for items and services.” We believe CMS could be referring to that 11% of hospitals using the web tool format as cause for their concern.

Consumer Shoppable Results

Of the 137 systems we looked at, 119 of them disclosed information for the consumer shoppable requirement using either a web-based tool (113) or a downloadable file (6).  Of the 119, we found that 15 likely would not be deemed compliant by lacking an uninsured option or creating some significant barrier to access.  Per accessibility, we found 90% of all web-based tools used CAPTCHA security coding, and several facilities had a member login as well as a guest user access for the tool itself. MyChart used this particular strategy. Many web tools asked for emails, but only a few required it. As far as the spirit of the rule, the goal should be to make the information accessible as possible to the customer, with the fewest barriers to entry.  In general, accessibility was something addressed in the CMS CY22 OPPS Proposed Rule which contained additional transparency comments.  You can find our summary of the transparency components of the rule here.

Language and Authorizations

In nearly half of the hospitals we looked at, the disclosures were behind some kind of authorization or use-agreement. We had to agree that we understood their terms before we could see the data. In one case, a health system made the user watch a video on the CDM and how pricing is determined before the user was able to access the file. Some hospitals included language urging patients to reach out if they did not understand the information provided or the format of the data.

It is clear that many hospitals and systems are concerned that patients may not fully understand the data, or be able to navigate it with confidence, and are worried that these patients will make a complex decision about their medical care on this limited understanding. For this reason, these disclaimers may be helpful, though we don’t know how patients react to this language or if they integrate it into their decision-making process.

As more hospitals become compliant and researchers aggregate data, we look forward to getting a better perspective on all these issues.

Summary

Our review suggests that a more limited number of hospitals/health systems are complying with the full set of machine-readable requirements (29%) but a far greater number are disclosing consumer shoppable information (87%).  The CMS CY22 OPPS Proposed Rule (summary here), seeks to increase the number of compliant hospitals by significantly raising the civil monetary penalties associated with non-compliance. 

If you have questions about your hospital’s strategy, please contact us here! If you would like to see a deeper dive into this data, and all our research on Price Transparency, check out our Spring Summit here.


Editor’s note: This is an excerpt from Hospitals Complying to CMS Price Transparency Requirements.

Article reprinted with permission.  



Monday, November 21, 2022

Coding For Vaccinations

With flu season just around the corner, and no end to the pandemic in site, this installment of “Spotlight on CPT” reviews and updates previous information provided on coding for vaccinations. 

Coding professionals who assign CPT codes for vaccinations must be aware that two codes will be needed in order to capture the entirety of the procedure; one code is for the administration of the vaccine (the actual injection itself), and the second code is for the vaccine or toxoid that is being given.  Let’s talk about the administration codes first.

CPT codes for the administration of a vaccine are broken down into three distinct groups.  The first group of codes (90460-90461) require that the physician or qualified healthcare professional provide counseling regarding the component(s) of the vaccine to the patient.  For this code group, the age of the patient is a factor with the age being through 18 years.  The second group of codes (90471-90474) are to be used when there is no counseling performed.  The breakdown of these codes is by the route of administration: either percutaneous, intradermal, subcutaneous, or intramuscular injection or via intranasal or oral route.  There is an add-on code for each of the base codes to identify any additional vaccines that may be administered.  The third set of administration codes are related to COVID immunizations.  These are identified by dose (first, second, single) and manufacturer.  A new CPT appendix, Appendix Q, was created to help coding professionals align the administration and vaccine codes for COVID vaccinations.     

Once the appropriate administration code has been chosen, the coding professional will need to determine the appropriate vaccine or toxoid code that should also be assigned.  In this coding step, it is important that the precise code for the vaccine/toxoid is assigned.  Different CPT codes exist for vaccines that have variations in chemical formulation (influenza vaccines for example), dosage (hepatitis A-adult vs. pediatric dosage for example), or route of administration (rabies-intradermal vs. intramuscular for example).

When assigning the vaccine/toxoid code, coding professionals should be aware that there are combination codes available.  Like with all other combination code guidelines, it is inappropriate to separately code for the individual components of a vaccine if a combination code exists.  For example, if an adult patient was to receive an intramuscular Hib-HepB vaccine, the appropriate code is 90478 and not 90739 and 90647.

As previously mentioned, it is important to assign the precise vaccine/toxoid code.  Should a coding professional encounter a vaccine that does not have a specific CPT code, an unlisted code (90479) should be reported instead.  Also, be aware that the coding for immune globulins does not fall into any of the previously mentioned categories of codes.  Instead, those codes are in the ranges of 90281-90399 (immune globulin) and 96365-96375 (administration).

Let’s look at two specific scenarios in order to apply the concepts noted above.  A 60 year-old female goes to a local pharmacy to get a Shingrix vaccine.  The pharmacist administers the vaccine intramuscularly in the left shoulder and provides information on possible side effects.  The CPT codes to assign are 90471 for the administration and 90750 for the Zoster vaccine.      

A 48 year-old male goes to a local pharmacy to get his second in the series of Pfizer vaccines against COVID-19.  By utilizing the Appendix Q table, we can see that the administration code for this vaccine will be 0002A for the second dose of the Pfizer COVID vaccine, and 91300 is the code that should be assigned for the vaccine itself. 

 

Now, light has been shed on coding for vaccinations.

 

 

 

 

About the Author 

Dianna Foley, RHIA, CCS, CHPS, CDIP  is OHIMA's Education Coordinator. Dianna has been an HIM professional for over 20 years. She progressed through the ranks of coder, department supervisor, and department director, to her current role as a coding consultant. 

She previously served as the program director for Medical Coding and HIT at Eastern Gateway Community College. Dianna earned her bachelor's degree from the University of Cincinnati and holds RHIA, CHPS, CDIP and CCS certifications. She is an AHIMA Approved ICD-10-CM/PCS Trainer and is a presenter on coding topics at the national, state, and regional levels. Dianna mentors new AHIMA members and also provides monthly educational lectures to coders and clinical documentation specialists.